Symbol | Exchange | Currency |
|---|
By Samuel IndykInvesting.com – Avacta Group (LON:AVCT) has announced that the next drug candidate using its proprietary pre|CISION platform has been selected for...
By Samuel IndykInvesting.com – Avacta Group (LON:AVCT) has announced that its AffiDX SARS-CoV-2 antigen lateral flow test has received a CE Mark for use as a consumer self-test in...
By Samuel IndykInvesting.com – Avacta Group PLC (LON:AVCT) has announced the appointment of Dr Fiona McLaughlin as Chief Scientific Officer of its Therapeutics Division, effective...
Here is a list of companies that were popular on the site in the latest week.British American TobaccoShares in British American Tobacco (LON:BATS) were popular on the site last...
GameStopThe GameStop Corp (NYSE:GME) squeeze was back this week amid hopes that the new stimulus checks will work their way into the stock market. After closing last week at...
Avacta Group plc is a United Kingdom-based clinical stage biopharmaceutical company. The Company is focused on developing cancer therapies and diagnostics based on its Affimer and prelCISION platforms. The Company operates through three segments: Diagnostics, Therapeutics and Animal Health. Its Diagnostics segment is engaged in the development of custom Affimer proteins for incorporation into customer products and in-house diagnostic assays. Its Therapeutics segment is engaged in the development of cancer immunotherapies combining its platforms. Its Animal Health segment is engaged in the provision of tools and contract services to assist diagnosis of conditions in animals to enable treatment for veterinarians. The Company's diagnostics division is focused on utilizing its Affimer platform to develop AffiDX in vitro diagnostic (IVD) tests, which include AffiDX SARS-CoV-2 Antigen Lateral Flow Test.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Sell | Buy | Buy | Strong Buy | Buy |
| Technical Indicators | Buy | Strong Buy | Strong Buy | Strong Buy | Strong Sell |
| Summary | Neutral | Strong Buy | Strong Buy | Strong Buy | Neutral |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 71.05 | 71.05 | 70.30 | +0.55 | +0.78% | 5.25M | London | |||
| 223.20 | 223.20 | 213.20 | +6.80 | +3.14% | 391.93K | London | |||
| 1,554.50 | 1,570.50 | 1,550.50 | 0.00 | 0.00% | 962.73K | London | |||
| 5.15 | 5.15 | 5.15 | +0.700 | +15.73% | 1.58M | London | |||
| 67.40 | 67.40 | 67.40 | -0.50 | -0.73% | 73.34K | London | |||
| 3,643.50 | 3,665.50 | 3,607.50 | +5.0 | +0.14% | 2.81M | London | |||
| 12.25 | 12.25 | 12.25 | -1.00 | -7.55% | 391.33K | London | |||
| 742.80 | 758.60 | 738.80 | -14.80 | -1.95% | 2.68M | London | |||
| 82.25 | 82.25 | 82.25 | 0.00 | 0.00% | 0.00 | London | |||
| 99.00 | 98.00 | 98.00 | 0.00 | 0.00% | 320.00 | Aquis Exchange | |||
| 24.70 | 25.34 | 24.46 | -0.04 | -0.16% | 5.32M | London | |||
| 6.70 | 6.70 | 6.70 | +0.350 | +5.51% | 5.57M | London | |||
| 131.00 | 131.00 | 130.00 | +0.50 | +0.38% | 845.65K | London | |||
| 83.60 | 84.00 | 83.50 | -0.20 | -0.24% | 697.26K | London | |||
| 1,494.00 | 1,508.00 | 1,470.00 | +12.00 | +0.81% | 30.91K | London |